Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.12.09
ag真人平台官方：关于延长员工持股计划存续期的公告
2022.12.09
ag真人平台官方：独立董事关于第五届董事会第二十四次会议相关事项的独立意见
2022.12.09
ag真人平台官方：第五届董事会第二十四次会议决议公告
2022.11.08
ag真人平台官方：2022年第二次临时股东大会决议公告
2022.10.28
ag真人平台官方：2022年三季度报告
2022.10.14
ag真人平台官方：H股公告
2022.10.01
ag真人平台官方：第五届监事会第十二次会议决议公告
2022.10.01
ag真人平台官方：第五届董事会第二十二次会议决议公告
2022.10.01
ag真人平台官方：独立董事关于第五届董事会第二十二次会议相关事项的独立意见
2022.10.01
ag真人平台官方：关于变更H股募集资金使用用途的公告
第一页
上一页
10
11
12
13
14
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
